APO Research
Talk to an analyst

APO RESEARCH · REPORT

Split Influenza Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Split Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025185 pages

Choose your research edition.

Industry ResearchSplit Influenza Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Split Influenza Vaccine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Split Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Split Influenza Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Split Influenza Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Split Influenza Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Split Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Split Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Split Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Split Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Split Influenza Vaccine include CSL Seqirus, Seqirus, Inc., straZeneca, Dalian Yali Peak, GSK and Sanofi Pasteur, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Split Influenza Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Split Influenza Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Split Influenza Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Split Influenza Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Split Influenza Vaccine Segment by Company

CSL Seqirus

Seqirus, Inc.

straZeneca

Dalian Yali Peak

GSK

Sanofi Pasteur

Split Influenza Vaccine Segment by Type

Aldult

Child

Split Influenza Vaccine Segment by Application

Hospital

Clinic

Split Influenza Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Split Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Split Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Split Influenza Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Split Influenza Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Split Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Split Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Split Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Split Influenza Vaccine Industry Trends Table 2. Split Influenza Vaccine Industry Drivers Table 3. Split Influenza Vaccine Industry Opportunities and Challenges Table 4. Split Influenza Vaccine Industry Restraints Table 5. Global Split Influenza Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Split Influenza Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Split Influenza Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Split Influenza Vaccine Sales Market Share by Manufacturers Table 9. Global Split Influenza Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Split Influenza Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Split Influenza Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Split Influenza Vaccine Manufacturers, Product Type & Application Table 13. Global Split Influenza Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Split Influenza Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Aldult Table 17. Major Manufacturers of Child Table 18. Global Split Influenza Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Split Influenza Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global Split Influenza Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global Split Influenza Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Split Influenza Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Split Influenza Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Split Influenza Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global Split Influenza Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global Split Influenza Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Split Influenza Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Split Influenza Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Split Influenza Vaccine Sales by Application (2021-2026) & (k units) Table 32. Global Split Influenza Vaccine Sales by Application (2027-2032) & (k units) Table 33. Global Split Influenza Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Split Influenza Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Split Influenza Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Split Influenza Vaccine Revenue by Application (2021-2026) & (k units) Table 37. Global Split Influenza Vaccine Revenue by Application (2027-2032) & (k units) Table 38. Global Split Influenza Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Split Influenza Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Split Influenza Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Split Influenza Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global Split Influenza Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Split Influenza Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Split Influenza Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Split Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Split Influenza Vaccine Sales by Country (2021-2026) & (k units) Table 47. North America Split Influenza Vaccine Sales by Country (2027-2032) & (k units) Table 48. Europe Split Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Split Influenza Vaccine Sales by Country (2021-2026) & (k units) Table 50. Europe Split Influenza Vaccine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Split Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Split Influenza Vaccine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Split Influenza Vaccine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Split Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Split Influenza Vaccine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Split Influenza Vaccine Sales by Country (2027-2032) & (k units) Table 57. Global Split Influenza Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Split Influenza Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Split Influenza Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Split Influenza Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Split Influenza Vaccine Revenue Market Share by Region (2027-2032) Table 62. CSL Seqirus Company Information Table 63. CSL Seqirus Business Overview Table 64. CSL Seqirus Split Influenza Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. CSL Seqirus Split Influenza Vaccine Product Portfolio Table 66. CSL Seqirus Recent Development Table 67. Seqirus, Inc. Company Information Table 68. Seqirus, Inc. Business Overview Table 69. Seqirus, Inc. Split Influenza Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Seqirus, Inc. Split Influenza Vaccine Product Portfolio Table 71. Seqirus, Inc. Recent Development Table 72. straZeneca Company Information Table 73. straZeneca Business Overview Table 74. straZeneca Split Influenza Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. straZeneca Split Influenza Vaccine Product Portfolio Table 76. straZeneca Recent Development Table 77. Dalian Yali Peak Company Information Table 78. Dalian Yali Peak Business Overview Table 79. Dalian Yali Peak Split Influenza Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Dalian Yali Peak Split Influenza Vaccine Product Portfolio Table 81. Dalian Yali Peak Recent Development Table 82. GSK Company Information Table 83. GSK Business Overview Table 84. GSK Split Influenza Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. GSK Split Influenza Vaccine Product Portfolio Table 86. GSK Recent Development Table 87. Sanofi Pasteur Company Information Table 88. Sanofi Pasteur Business Overview Table 89. Sanofi Pasteur Split Influenza Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sanofi Pasteur Split Influenza Vaccine Product Portfolio Table 91. Sanofi Pasteur Recent Development Table 92. Key Raw Materials Table 93. Raw Materials Key Suppliers Table 94. Split Influenza Vaccine Distributors List Table 95. Split Influenza Vaccine Customers List Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Split Influenza Vaccine Product Image Figure 2. Global Split Influenza Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Split Influenza Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Split Influenza Vaccine Sales (2021-2032) & (k units) Figure 5. Global Split Influenza Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Split Influenza Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Aldult Image Figure 9. Child Image Figure 10. Global Split Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Split Influenza Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Split Influenza Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Split Influenza Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Split Influenza Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Split Influenza Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Split Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Split Influenza Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Split Influenza Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Split Influenza Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Split Influenza Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Split Influenza Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Split Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Split Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Split Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Split Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Split Influenza Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Split Influenza Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Split Influenza Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Split Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Split Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Split Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Split Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Split Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Split Influenza Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Split Influenza Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Aldult
  • Child
Applications
  • Hospital
  • Clinic
Companies covered
  • CSL Seqirus
  • Seqirus, Inc.
  • straZeneca
  • Dalian Yali Peak
  • GSK
  • Sanofi Pasteur

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Split Influenza Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Split Influenza Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Split Influenza Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Split Influenza Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Split Influenza Vaccine Market Dynamics
  1. 2.1 Split Influenza Vaccine Industry Trends
  2. 2.2 Split Influenza Vaccine Industry Drivers
  3. 2.3 Split Influenza Vaccine Industry Opportunities and Challenges
  4. 2.4 Split Influenza Vaccine Industry Restraints
3 Split Influenza Vaccine Market by Manufacturers
  1. 3.1 Global Split Influenza Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Split Influenza Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Split Influenza Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Split Influenza Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Split Influenza Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Split Influenza Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Split Influenza Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Split Influenza Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Split Influenza Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Split Influenza Vaccine Tier 1, Tier 2, and Tier 3
4 Split Influenza Vaccine Market by Type
  1. 4.1 Split Influenza Vaccine Type Introduction
  2. 4.1.1 Aldult
  3. 4.1.2 Child
  4. 4.2 Global Split Influenza Vaccine Sales by Type
  5. 4.2.1 Global Split Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Split Influenza Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Split Influenza Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Split Influenza Vaccine Revenue by Type
  9. 4.3.1 Global Split Influenza Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Split Influenza Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Split Influenza Vaccine Revenue Market Share by Type (2021-2032)
5 Split Influenza Vaccine Market by Application
  1. 5.1 Split Influenza Vaccine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Split Influenza Vaccine Sales by Application
  5. 5.2.1 Global Split Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Split Influenza Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Split Influenza Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Split Influenza Vaccine Revenue by Application
  9. 5.3.1 Global Split Influenza Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Split Influenza Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Split Influenza Vaccine Revenue Market Share by Application (2021-2032)
6 Global Split Influenza Vaccine Sales by Region
  1. 6.1 Global Split Influenza Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Split Influenza Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Split Influenza Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Split Influenza Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Split Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Split Influenza Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Split Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Split Influenza Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Split Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Split Influenza Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Split Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Split Influenza Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Split Influenza Vaccine Revenue by Region
  1. 7.1 Global Split Influenza Vaccine Revenue by Region
  2. 7.1.1 Global Split Influenza Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Split Influenza Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Split Influenza Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Split Influenza Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Split Influenza Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Split Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Split Influenza Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Split Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Split Influenza Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Split Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Split Influenza Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Split Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CSL Seqirus
  2. 8.1.1 CSL Seqirus Company Information
  3. 8.1.2 CSL Seqirus Business Overview
  4. 8.1.3 CSL Seqirus Split Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CSL Seqirus Split Influenza Vaccine Product Portfolio
  6. 8.1.5 CSL Seqirus Recent Developments
  7. 8.2 Seqirus, Inc.
  8. 8.2.1 Seqirus, Inc. Company Information
  9. 8.2.2 Seqirus, Inc. Business Overview
  10. 8.2.3 Seqirus, Inc. Split Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Seqirus, Inc. Split Influenza Vaccine Product Portfolio
  12. 8.2.5 Seqirus, Inc. Recent Developments
  13. 8.3 straZeneca
  14. 8.3.1 straZeneca Company Information
  15. 8.3.2 straZeneca Business Overview
  16. 8.3.3 straZeneca Split Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 straZeneca Split Influenza Vaccine Product Portfolio
  18. 8.3.5 straZeneca Recent Developments
  19. 8.4 Dalian Yali Peak
  20. 8.4.1 Dalian Yali Peak Company Information
  21. 8.4.2 Dalian Yali Peak Business Overview
  22. 8.4.3 Dalian Yali Peak Split Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Dalian Yali Peak Split Influenza Vaccine Product Portfolio
  24. 8.4.5 Dalian Yali Peak Recent Developments
  25. 8.5 GSK
  26. 8.5.1 GSK Company Information
  27. 8.5.2 GSK Business Overview
  28. 8.5.3 GSK Split Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GSK Split Influenza Vaccine Product Portfolio
  30. 8.5.5 GSK Recent Developments
  31. 8.6 Sanofi Pasteur
  32. 8.6.1 Sanofi Pasteur Company Information
  33. 8.6.2 Sanofi Pasteur Business Overview
  34. 8.6.3 Sanofi Pasteur Split Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi Pasteur Split Influenza Vaccine Product Portfolio
  36. 8.6.5 Sanofi Pasteur Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Split Influenza Vaccine Value Chain Analysis
  2. 9.1.1 Split Influenza Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Split Influenza Vaccine Production Mode & Process
  6. 9.2 Split Influenza Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Split Influenza Vaccine Distributors
  9. 9.2.3 Split Influenza Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst